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December 20121820 Abstractsaneurysm neck but a right renal artery supplied from the body of the
aneurysm. Given the severity of his pulmonary disease, risk of emboliza-
tion of his renal arteries, as well as difficulty of cross-clamping the aorta
with the horseshoe kidney, the decision was made to perform an EVAR
with preservation of his right renal artery. The left common femoral
artery aneurysm was excised and replaced with a 10-mmDacron graft and
an Endurant (Medtronic, Minneapolis, Minn) main body deployed via
the left common femoral artery. His iliac arteries were severely tortuous,
making cannulation of the contralateral gate extremely difficult, so the
gate was cannulated via left brachial access. An occlusion plug was used to
occlude the gate and convert the endograft into an aortouniiliac system.
The right renal artery was then serially stented with two iCAST (Atrium
Medical Corp, Hudson, NH) stents, a Viabahn (W L Gore & Associates,
Flagstaff, Ariz) stent, and two Endurant limb extensions into the distal
common iliac artery. A femoral-femoral bypass was then performed to
provide left leg perfusion (Fig).
Results: Completion angiography demonstrated straight-line flow
from the aorta to the right iliac limb, across the femoral-femoral bypass with
perfusion of the right renal artery via retrograde filling of the left common
iliac artery with no evidence of a leak. Follow-up computed tomography at
2 weeks demonstrated filling of the right renal artery and entirety of the
horseshoe kidney, with no evidence of endoleak. His creatinine remained at
0.9 postoperatively.
Conclusions: Patients presenting with both AAA and horseshoe kid-
neys are rare, reported in the literature as only 0.12% of AAAs. This patient
presented with the challenging anatomy of not only a horseshoe kidney but
also a perirenal AAA. Options included reimplantation or ligation of the
right renal artery, but would have necessitated an open surgery or worsened
renal failure in this patient. The complex aneurysm repair chosen demon-
strates an alternative method, allowing for preservation of the perfusion and
function of his horseshoe kidney.
Pulmonary Embolism Risk Following Upper Extremity DVT in a
Single-Center Series of 500 Consecutive Patients
Ayorinde Akinrinlola, Francisco C. Albuquerque, Micheal F. Amendola,
Mark M. Levy. Virginia Commonwealth University, Richmond, Va
Introduction: The reported incidence of pulmonary embolism (PE)
associated with isolated upper extremity deep venous thrombosis (UEDVT)
is variable (1%-13%). As per Chest 2008 guidelines, many clinicians treat
UEDVTwith anticoagulation to ameliorate symptoms, and decrease the risk
of subsequent PE. After the analysis of a smaller cohort of UEDVT patients,
we had previously reported a low risk of PE attributable toUEDVT.We here
expand our analysis to 500 UEDVT patients and compare the observed
outcomes for PE and hemorrhagic risk among anticoagulated (AC) and
non-AC (NAC) patients.
Methods: Between April 2005 and July 2010, 500 consecutive
UEDVT patients were identified from a prospectively maintained registry. A
retrospective analysis was then performed among AC and NAC patients,
comparing patient demographics and outcomes as well as UEDVT charac-
teristics. The decision to anticoagulate patients reflected the judgment of the
treating physicians and was not randomized.
Results: UEDVTs were identified in the distal innominate (n  113),
internal jugular (n  239), subclavian (n  261), axillary (n  190), and
brachial veins (n 164), with many patients having multiple named venous
segments involved. Most UEDVTs had sonographically acute components
(86%). Among the 500 patients, 297 were AC (59%), and 203 were NAC.
There were 403 patients (81%) with catheter-associated UEDVT. Most
patients were symptomatic, and the AC patients had more UEDVT seg-
ments involved (Table). There were no statistically significant differences in
the treatment groups related to trauma or postoperative status, malignancy,
renal failure, diabetes, coronary artery disease, or obesity. AC patients were
younger than NAC patients, with less associated comorbidities. The NAC
group demonstrated decreased survival, perhaps owing to older patient age
and more comorbidities, but not due to increased PE rates. The overall rate
of UEDVT-associated PE was 3%, with no associated mortality. Among the
15 patients suffering PE in association with their UEDVT, eight presented
with simultaneous PE and UEDVT, and were AC. Only seven patients
suffered PE subsequent to a primary diagnosis of UEDVT, of which most (5
of 7) were AC. After hospital discharge, four of the UEDVT patients treated
with anticoagulation developed fatal intracranial bleeds. Seven additional
patients had their anticoagulation discontinued early due to hemorrhagic
complications requiring hospital readmission and transfusion.
Conclusions: We continue to observe that clinicians choose to antico-
agulate UEDVT patients that are younger, with more extensive thrombus
burdens. The risk of PE subsequent to UEDVT diagnosis remains small
however, and we observed no evidence that anticoagulation dampens this
risk. In light of the persistent risk of hemorrhagic complications demon-
strated among this fragile patient group, our patient outcomes do not
support routine anticoagulation among UEDVT patients.
l
fable.
atient/UEDVT characteristics
NAC AC
P(n  203) (n  297)
atient age, years 54  17 50  18 .02a
ortality at 3 months, No. (%) 57 (28) 44 (15) .0001b
ymptomatic, No. (%) 174 (86) 268 (90) .12b
EDVT-associated PE, No. (%) 2 (1.0) 13 (4) .022b
alignancy, No. (%) 77 (38) 96 (32) .12b
amed DVT segments, No 1.7  1.0 2.1  1.1 .0001a
t test; b2
arly Outcomes After Inferior Vena Cava Thrombectomy and Recon-
truction For Advanced Renal Cell Carcinoma With Tumor Thrombus
aul A. Armstrong,1 Megan I. Caroll,1 Martin R. Back,1 Murray L. Shames,1
amuel M. Lawindy,1 Wade J. Sexton,2 Philippe E. Spiess2. 1University of
outh Florida, Tampa, Fla; 2Moffitt Cancer Center, Tampa, Fla
Introduction: Advanced-stage renal cell carcinoma (RCC) with and
nferior vena cava (IVC) thrombus is associated with poor clinical outcomes.
his report details the results of a multidisciplinary surgical team who
ddresses the surgical component of stage III and IV RCC.
Methods: A retrospective inquiry of our vascular database from 2003
o 2012 identified 55 surgical cases done for stage III (n 40) and stage IV
n  15) RCC. The character of tumor and inferior vena cava (IVC) tumor
hrombus was evaluated by clinical staging preoperatively and pathology
taging postoperatively. Patient demographics and surgical reconstruction is
etailed. Reconstructions were evaluated by oncologic surveillance with
omputed tomography (CT) ormagnetic resonance (MR) imaging. Patients
eceived venous thromboembolism (VTE) prophylaxis. Antiplatelet therapy
as continued if indicated medically. A Clavien-Dindo classification of early
30-day) surgical complications and mortality was recorded, including a
eview of secondary surgical interventions.
Results: According to Novick classification for IVC thrombus, there
ere 10 diaphragmatic (level IV), 20 retrohepatic (level III), and 25
nfrahepatic (level II or I) tumor thrombi. IVC reconstruction was com-
leted in 54 patients (98%), with one patient deemed unresectable. IVC
ontrol required cardiac bypass (n  10), venovenous bypass (n  4), or
nfrahepatic IVC control (n  40). Reconstruction of the IVC was com-
leted with two prosthetic interposition grafts done for one stage IV and one
tage III thrombus, two patch repairs done for stage III thrombus, and 50
rimary IVC repairs. VTE prophylaxis involved sequential compression
evices (n  54), unfractionated or fractionated heparin (n  17). Antico-
gulation with heparin and warfarin was administered for two patients with
ostoperative pulmonary embolus and one patient with chronic bilateral
leofemoral venous thrombosis. No other hospital VTE events occurred, and
ll other IVC reconstructions were patent at a mean follow-up of 23months.
ne asymptomatic patient with primary ICV repair had estimated 30% IVC
arrowing but no other measurable stenosis as detected by postoperative
maging. Three patients required reoperation (2 for surgical site bleeding, 1
or small-bowel fistula). Early surgical complications included Clavien-
indo classification grade I (n  3), II (n  6), IIIa (n  2), IIIb (n  3),
nd V (n  2). Regional retroperitoneal or distant recurrent RCC occurred
n 26 patients (48%), with one patient demonstrating recurrent IVC tumor
hrombus at 8 months requiring secondary IVC thrombectomy. All patients
ith tumor invasion of the IVC wall developed recurrent RCC, and no
atient survived 5 years. Early mortality was 3.6% (n 2), with an additional
7 patients (49%) dying within 24 months and an overall group mortality of
0% (n  44) during surveillance.
Conclusions: A multidisciplinary approach for perioperative manage-
ent of advanced RCC helps optimize surgical outcomes. Primary IVC
epairs are possible in most patients, and IVC patency is good without use of
omplex anticoagulation protocols. Early IVC recurrent thrombus rates are
ow; however, RCC tumor recurrence and mortality is high among patients
ith advanced cancers with IVC wall invasion.
utcracker Syndrome in a Pelvic Kidney Treated With Open Iliac Vein
econstruction
ames Jen, Sharif Ellozy, Jeffrey Saland, Anna Rosenblatt, Michael Marin,
eter Faries. Mount Sinai Medical Center, New York, NY
Introduction: To our knowledge, this is the only reported case of
utcracker syndrome occurring in a left pelvic kidney. This resulted from
ompression of the left renal vein outflow by the overlying right common
liac artery. We treated this condition with a novel operation in which we
ransposed the left iliac vein anterior to the iliac artery.
Methods: An 18-year-old woman presented with left lower quadrant
bdominal pain, worsening hematuria, and anemia. She was found to have a
eft pelvic kidney, and subsequent cystoscopy demonstrated bloody urine
rom the left ureter. Subsequent magnetic resonance angiography and
